期刊
TETRAHEDRON
卷 79, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.tet.2020.131836
关键词
sp(3)-rich scaffold; Chemical library; Hydrazine; 1,2-Diazetidine; Epoxide opening
资金
- Leverhulme Trust [RPG-2014-362]
- Eli Lilly
- University of Warwick
- European Research Council under the European Union [637313]
- European Research Council (ERC) [637313] Funding Source: European Research Council (ERC)
This study presents a strategy for drug discovery by creating sp(3)-rich, non-planar scaffolds using stereo-controlled reactions to generate 1,2-diazetidines. The resulting chemical library is characterized by significant sp(3)-character with nitrogen substituents in an anti-configuration.
A strategy for the creation of sp(3)-rich, non-planar scaffolds for drug discovery is described. Stereo-controlled ring opening of homochiral 1,2-epoxides by hydrazine monohydrate followed by selective protection of both nitrogen atoms and Mitsunobu ring closure gives differentially protected, enantiomerically pure 1,2-diazetidines (up to 98% ee) bearing a variety of C-3 substituents. Iterative CeN functionalization at the two nitrogen atoms using a range of chemistries and coupling partners produces a 1,2-diazetidine based chemical library. Crystallographic data confirm that these frameworks display significant sp(3)-character with the nitrogen substituents adopting an anti-configuration. (C) 2020 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据